FDMT 8-K: SEC filing
4D Molecular Therapeutics
Filed with the SEC on · accession 0001193125-26-458394
FDMT filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -6.7% by the first close after the filing.
Summary of the filing
4D Molecular Therapeutics announced its financial results for the three months ended September 30, 2026, along with operational highlights and expected upcoming milestones.
Key details
How FDMT stock reacted
Close before
$12.99
Nov 11, 2026
First close after
-6.74%
$12.12
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for FDMT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FDMT?
Click hereFrequently asked questions
What did FDMT file with the SEC on Nov 12, 2026?
FDMT filed a 8-K (SEC filing). 4D Molecular Therapeutics announced its financial results for the three months ended September 30, 2026, along with operational highlights and expected upcoming milestones.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did FDMT stock react to this filing?
FDMT closed at $12.99 before the filing and $12.12 on Nov 12, 2026 (-6.74%).
Other FDMT SEC filings
- 10-Q · SEC filingNov 12, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 8-K · Fda approvalSep 28, 2026
- 8-K · Guidance raiseAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Fda approvalJul 20, 2026
- 144 · Insider sale plannedJul 10, 2026
- 144 · Insider sale plannedJul 9, 2026
- 144 · Insider sale plannedJun 30, 2026
- 8-K · Material agreementJun 29, 2026
Get alerts when FDMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days